Preprint · OA
via OpenAlex
Rapalogs and mTOR inhibitors as anti-aging therapeutics
Dudley W. Lamming, Lan Ye, David M. Sabatini, Joseph A. Baur
Journal of Clinical Investigation · 2013 · ▲ 547 citations
Deregulated nutrient-sensing
Altered intercellular communication
Rapamycin / mTOR inhibition
Human
Mouse
Review
Abstract
mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">Rapamycin(definition), an inhibitor of mechanistic target of rapamycin (mTOR), has the strongest experimental support to date as a potential anti-aging therapeutic in mammals. Unlike many other compounds that have been claimed to influence longevity, rapamycin has been repeatedly tested in long-lived, genetically heterogeneous mice, in which it extends both mean and maximum life spans. However, the mechanism that accounts for these effects is far from clear, and a growing list of side effects make it doubtful that rapamycin would ultimately be beneficial in humans. This Review discusses the prospects for developing newer, safer anti-aging therapies based on analogs of rapamycin (termed rapalogs) or other approaches targeting mTOR signaling.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1172/jci64099
- Canonical
- link ↗
- Fetched
- 2026-11-11 MST
Cite this
APA
Lamming, D.W., Ye, L., Sabatini, D.M., & Baur, J.A. (2013). Rapalogs and mTOR inhibitors as anti-aging therapeutics. <em>Journal of Clinical Investigation</em>. https://doi.org/10.1172/jci64099
Vancouver
Lamming DW, Ye L, Sabatini DM, Baur JA. Rapalogs and mTOR inhibitors as anti-aging therapeutics. Journal of Clinical Investigation. 2013. doi:10.1172/jci64099.
BibTeX
@unpublished{dudley2013Rapalo,
title = {Rapalogs and mTOR inhibitors as anti-aging therapeutics},
author = {Dudley W. Lamming and Lan Ye and David M. Sabatini and Joseph A. Baur},
journal = {Journal of Clinical Investigation},
year = {2013},
doi = {10.1172/jci64099},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Stem Cell Research & Therapy 2025
Open access · CC-BY
The role of the mTOR pathway in breast cancer stem cells (BCSCs): mechanisms and therapeutic potentials
Cells 2019
Open access · CC-BY
Targeting mTOR and Metabolism in Cancer: Lessons and Innovations
Translational Medicine of Aging 2020
Open access · CC-BY
RTB101 and immune function in the elderly: Interpreting an unsuccessful clinical trial
Innovation in Aging 2019
Open access · CC-BY
TARGETING THE MTOR NETWORK TO MAXIMIZE HEALTHSPAN
Interdisciplinary topics in gerontology and geriatrics 2013
Citation only
Chronic Mechanistic Target of Rapamycin Inhibition: Preventing Cancer to Delay Aging, or Vice Versa?
Cell Reports 2019
Open access · CC-BY